Quote | Ensysce Biosciences Inc. (NASDAQ:ENSC)
Last: | $0.45 |
---|---|
Change Percent: | 2.95% |
Open: | $0.4613 |
Close: | $0.45 |
High: | $0.499 |
Low: | $0.439 |
Volume: | 57,145 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Ensysce Biosciences Inc. (NASDAQ:ENSC)
~ Geoff Birkett, Chief Commercial Officer, Provides Insight Following EPHMRA Meeting ~ SAN DIEGO, CA / ACCESSWIRE / June 27, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical stage pharmaceutical company developing innovative solutions for severe pain r...
~ Collaboration with Purisys Positions Ensysce to Expedite Lead OUD Candidate, PF9001, to IND Studies ~ SAN DIEGO, CA / ACCESSWIRE / June 25, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions ...
Message Board Posts | Ensysce Biosciences Inc. (NASDAQ:ENSC)
Subject | By | Source | When |
---|---|---|---|
nsysce Biosciences Announces Successful Completion of Ground-Breaking Study | subslover | investorshub | 05/09/2023 1:27:57 PM |
Time for a bounce? | PennyPusher786 | investorshub | 05/04/2023 7:09:57 PM |
$ENSC great article | PennyPusher786 | investorshub | 05/04/2023 3:41:14 PM |
news out | Shift-4 | investorshub | 04/30/2023 8:47:52 PM |
should we be shorting? | Hercules1 | investorshub | 04/29/2023 5:04:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Ensysce Biosciences Inc. Company Name:
ENSC Stock Symbol:
NASDAQ Market:
Ensysce Biosciences Inc. Website:
~ Geoff Birkett, Chief Commercial Officer, Provides Insight Following EPHMRA Meeting ~ SAN DIEGO, CA / ACCESSWIRE / June 27, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical stage pharmaceutical company developing innovative solutions for severe pain r...
~ Collaboration with Purisys Positions Ensysce to Expedite Lead OUD Candidate, PF9001, to IND Studies ~ SAN DIEGO, CA / ACCESSWIRE / June 25, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions ...
~ Selects Lead Candidate with Abuse Deterrence and Improved Safety Profile to Treat Opioid Use Disorder ~ SAN DIEGO, CA / ACCESSWIRE / June 6, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions...